RE: Is the frustration good or bad.5 Sep 2022 14:15
From most recent RNS of 15 July:
"We continue to make good progress in understanding how Nuvec® can be used in the oncology space and this work, combined with the potential opening up of the siRNA market and the early data coming from UQ on their oral work, gives us a lot of material to further focus our route to commercial success.
"We will provide a further update of this along with our interim results."
Last year's interims up to end of June were released on 20 Sep. GLA